Apertor Pharmaceuticals
Pre-clinicalApertor Pharmaceuticals develops novel small molecule therapeutics targeting protein-protein interactions for oncology and other diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $4.8M
About
Apertor Pharmaceuticals develops novel small molecule therapeutics targeting protein-protein interactions for oncology and other diseases.
Small Molecules
Funding History
1Total raised:$4.8M
Seed$4.8MAug 15, 2020